| Статус: | Unknown status |
| Фаза: | Phase 3 |
| Начало: | 7 сентября 2020 г. |
| Окончание: | 1 мая 2021 г. |
| Описание: | Randomized, double-blind (blinded for the trial subject and the study physician), placebo controlled, multi-center clinical trial in parallel assignment of efficacy, immunogenicity, and safety of the Gam-COVID-Vac combined vector vaccine against the SARS-CoV-2-induced coronavirus infection in adults in the SARS-СoV-2 infection prophylactic treatment. |
| смотреть на ClinicalTrials.gov |